We are a research organization dedicated to better understanding the roots of disease and narrowing the gap between new biological insights and impact for patients. We are committed to characterizing psychiatric disorders' molecular roots and turning new findings into new treatments. We are fostering a diverse research community engaged in innovative chemical biology and therapeutic research. The mission of the Broad Institute of MIT and Harvard is to better understand the roots of disease and narrow the gap between new biological insights and impact for patients. The Broad Institute of MIT and Harvard is a research organization that convenes a community of researchers from across many disciplines and partner institutions—MIT, Harvard, and Harvard-affiliated hospitals. Based in Cambridge, Massachusetts, the Broad Institute was founded in 2004 to fulfill the promise of genomic medicine—three years after completion of the Human Genome Project, which Broad scientists helped create and lead. Our researchers are deeply collaborative, nimbly launching innovative, high-risk projects at every scale, gaining insight into the biological mechanisms of disease, inventing new technologies, building and implementing computational tools, developing new therapeutics to advance into the clinic, mentoring and training the next generation of scientists, and sharing our data and tools openly to enable breakthroughs anywhere. We work with researchers and patients to tackle important challenges in biomedicine and find innovative, high-impact solutions.
Cambridge, United States
Founded in 2003
501-1000 Employees
Medium-Sized
Working industry
Research
Type of company
Educational institution, Manufacturer
Ownership structure
Nonprofit
Locations
2 Locations
Number of products
1 Product
Number of services
1 Service
Specialised areas
Metabolite profiling, Professional, Scientific, and Technical Services, Medical and population genetics, Research, Psychiatric disease, Biotechnology, Finance and Insurance, Metabolism, Proteomics, RNAi
Broad Institute offers a wide range of products and services
Service
Methods and Compositions for Targeting Developmental and Oncogenic Programs in H3K27M Gliomas | Broad Institute
Go to product >
Product
Platforms for Human Genetics | Broad Institute
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United States
Overall risk estimation:
Low
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Get insights into the use cases of Broad Institute
Use case
Goal I: 1,000 reference genomes | Broad Institute
One of the goals of the Human Microbiome Project is to sequence 1,000 microbial genomes. Although the number of microbial species associated with the human body is predicted to be many times this number, these genome sequences will establish a valuable benchmark for understanding microbial communities and will enable more complex metagenomic studies. These genome sequences represent five broad environments of the human body:
Broad Institute operates in 1 country around the world
Get an overview of the locations of Broad Institute
Location
Country
State
City
Headquarter
United States
Massachusetts
Cambridge
United States Office
United States
-
-
Some frequent questions that have been asked about Broad Institute
Where is Broad Institute located?
The company headquarter of Broad Institute is located in Cambridge, Massachusetts, United States. Broad Institute has subsidiaries in United States
How many employees does Broad Institute approximately have?
As of the latest available information Broad Institute has around 501-1000 employees worldwide.
When was Broad Institute founded?
Broad Institute was founded in 2003
In which industries does Broad Institute mainly work?
The company Broad Institute has it's main focus in the industries of Research
What is the current company status of Broad Institute?
Based on the founding year and the amount of employees the company Broad Institute seems to be a Medium-Sized at the current state. Note that over time that status can change
Check out some interesting alternative companies to Broad Institute
Bill & Melinda Gates Medical Research Institute
Cambridge, United States
51-100 Employees
2017
We are a diverse group of creative innovators and advocates. We are committed to the development and use of biomedical interventions to address global health concerns. We are a diverse group of passionate change-makers, creative fixers and relentless advocates. We are committed to saving lives by improving the pace and predictability of translational medicine in global health. The Bill & Melinda Gates Medical Research Institute is a non-profit organization dedicated to the development and effective use of novel biomedical interventions addressing substantial global health concerns, for which investment incentives are limited. The Bill & Melinda Gates Medical Research Institute is a non-profit organization dedicated to the development and effective use of novel biomedical interventions addressing substantial global health concerns and for which the required development investment by traditional biopharmaceutical organizations is lacking.
Indiana Biosciences Research Institute, Inc.
Indianapolis, United States
11-50 Employees
2013
While we are still on the ambitious path envisioned by our founders, we are taking what we’ve learned, building new capabilities and applying it to other diseases, such as Alzheimer’s disease and cancer. We are positioned with a unique interface to academia, industry and government research. At the IBRI, we are guided by five core values:. Our institute was founded on the mission to improve the health of Hoosiers who were living with diabetes. To become a leading independent research institute in the discovery and development of innovative solutions to improve human health. To build a world-class organization of researchers, innovators and business professionals that catalyze innovative research across the life sciences community. The Indiana Biosciences Research Institute (IBRI) is a leading translational research institute that advances academic and industry science through collaboration to improve patient health outcomes.
Eidos Therapeutics
Palo Alto, United States
11-50 Employees
2013
We are working to create a bridge between promising genetic research and actual medicines with the people, platform, and processes needed to advance many therapies simultaneously. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. Our goal is to not simply accept the ideas and opinions of others as fact, but instead to ask “why?” and “why not?” We endeavor to bring a rigorous, first-principles mindset to each problem that we take on. BridgeBio is committed to developing leaders as well as drugs. BridgeBio’s mission is to improve the morbidity and mortality of patients with ATTR through the discovery and development of a novel therapeutic through its affiliate, Eidos Therapeutics. To discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Capabilities built to deliver genetic medicines to patients globally. Our decentralized model strives to deliver treatments from discovery to patients as fast as possible by utilizing focused teams of experts for each asset.
BioInfoBank Institute
Poland
11-50 Employees
2000
Our mission is to create, inspire and incubate innovative ideas in life-sciences. The main scientific focus of the institute is bioinformatics, an inter-disciplinary field of science driven by achievements in biotechnology and information technology. The fourth research area is the design of application specific integrated circuits (ASICs). The results of our work are worldwide innovative technological and biomedical solutions. Some of them are converted into commercial projects that can be disseminated across the BioInfoBank network and developed through a spin-off program.
Probius
Fremont, United States
11-50 Employees
2016
Bridging biology and AI, to improve human health. We strive to extend the boundaries of what is possible. We help our partners and customers solve projects at all levels of complexity. We foster the spirit of innovation by promoting open-mindedness and collaboration. We build upon our shared scientific knowledge, to take responsible risks together.
N.A. Genomics
New York, United States
1-10 Employees
2011
We are now working with a top academic institution that has bred mice with our son's mutations in order to research the disease and develop potential treatments. Our organization is dedicated to the premise that computer technology will revolutionize healthcare, and the experience of our team reflects that conviction. We have multiple PhDs in computer science and biology, from leading institutions such as Caltech and Rockefeller University. We have MDs from Harvard and Stanford, two of the world's leading academic hospitals. So if you have specific areas of interest, we are happy to field special requests as to how your genome may relate. We report anything we can find about your DNA, so long as there is a peer-reviewed, published paper to back it up.